Initiation of antidepressants in young adults after ischemic stroke: a registry-based follow-up study.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 06 03 2021
accepted: 18 06 2021
revised: 16 06 2021
pubmed: 25 6 2021
medline: 27 1 2022
entrez: 24 6 2021
Statut: ppublish

Résumé

Data on post-stroke use of antidepressants in young individuals are scarce. We examined pattern and factors associated with initiating post-stroke antidepressants (PSAD) after ischemic stroke (IS) in young adults. Helsinki Young Stroke Registry includes patients aged 15-49 years with first-ever IS, 1994-2007. Data on prescriptions, hospitalizations and death came from nationwide registers. We defined time of initiating PSAD as time of the first filled prescription for antidepressants within 1 year from IS. We assessed factors associated with initiating PSAD with multivariable Cox regression models, allowing for time-varying effects when appropriate. We followed 888 patients, of which 206 (23.2%) initiated PSAD. Higher hazard of starting PSAD within the first 100 days appeared among patients with mild versus no limb paresis 2.53 (95% confidence interval 1.48-4.31) and during later follow-up among those with silent infarcts (2.04; 1.27-3.28), prior use of antidepressants (2.09; 1.26-3.46) and moderate versus mild stroke (2.06; 1.18-3.58). The relative difference in the hazard rate for moderate-severe limb paresis persisted both within the first 100 days (3.84, 2.12-6.97) and during later follow-up (4.54; 2.51-8.23). The hazard rate was higher throughout the follow-up among smokers (1.48; 1.11-1.97) as well as lower (1.78; 1.25-2.54) and upper white-collar workers (2.00; 1.24-3.23) compared to blue-collar workers. One-fourth of young adults started PSADs within 1 year from IS. We identified several specific clinical characteristics associated with PSAD initiation, highlighting their utility in assessing the risk of post-stroke depression during follow-up.

Identifiants

pubmed: 34165628
doi: 10.1007/s00415-021-10678-4
pii: 10.1007/s00415-021-10678-4
pmc: PMC8782780
doi:

Substances chimiques

Antidepressive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

956-965

Informations de copyright

© 2021. The Author(s).

Références

Hackett ML, Yapa C, Parag V, Anderson CS (2005) Frequency of depression after stroke. Stroke 36:1330–1340. https://doi.org/10.1161/01.STR.0000165928.19135.35
doi: 10.1161/01.STR.0000165928.19135.35 pubmed: 15879342
Ayerbe L, Ayis S, Wolfe CDA, Rudd AG (2013) Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry 202:14–21. https://doi.org/10.1192/bjp.bp.111.107664
doi: 10.1192/bjp.bp.111.107664 pubmed: 23284148
Towfighi A, Ovbiagele B, El Husseini N et al (2017) Poststroke depression: a scientific statement for healthcare professionals from the American heart association/american stroke association. Stroke. https://doi.org/10.1161/STR.0000000000000113
doi: 10.1161/STR.0000000000000113 pubmed: 27932603
Ayerbe L, Ayis S, Crichton S (2014) The long-term outcomes of depression up to 10 years after stroke; the south london stroke register. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2013-306448
doi: 10.1136/jnnp-2013-306448 pubmed: 24163430
Mitchell AJ, Sheth B, Gill J et al (2017) Prevalence and predictors of post-stroke mood disorders: a meta-analysis and meta-regression of depression, anxiety and adjustment disorder. Gen Hosp Psychiatry 47:48–60. https://doi.org/10.1016/j.genhosppsych.2017.04.001
doi: 10.1016/j.genhosppsych.2017.04.001 pubmed: 28807138
Jørgensen TSH, Wium-Andersen IK, Wium-Andersen MK et al (2016) Incidence of depression after stroke, and associated risk factors and mortality outcomes, in a large cohort of danish patients. JAMA Psychiat 73:1032–1040. https://doi.org/10.1001/jamapsychiatry.2016.1932
doi: 10.1001/jamapsychiatry.2016.1932
Waje-Andreassen U, Thomassen L, Jusufovic M et al (2013) Ischaemic stroke at a young age is a serious event—final results of a population-based long-term follow-up in Western Norway. Eur J Neurol 20:818–823. https://doi.org/10.1111/ene.12073
doi: 10.1111/ene.12073 pubmed: 23293975
Naess H, Nyland HI, Thomassen L et al (2005) Mild depression in young adults with cerebral infarction at long-term follow-up: a population-based study. Eur J Neurol 12:194–198. https://doi.org/10.1111/j.1468-1331.2004.00937.x
doi: 10.1111/j.1468-1331.2004.00937.x pubmed: 15693808
Ayerbe L, Ayis S, Crichton SL et al (2014) Explanatory factors for the increased mortality of stroke patients with depression. Neurology 83:2007–2012. https://doi.org/10.1212/WNL.0000000000001029
doi: 10.1212/WNL.0000000000001029 pubmed: 25355829 pmcid: 4248453
Pan A, Sun Q, Okereke OI et al (2011) Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 306:1241–1249. https://doi.org/10.1001/jama.2011.1282
doi: 10.1001/jama.2011.1282 pubmed: 21934057 pmcid: 3242806
Chemerinski E, Robinson RG, Kosier JT (2001) Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke 32:113–117. https://doi.org/10.1161/01.STR.32.1.113
doi: 10.1161/01.STR.32.1.113 pubmed: 11136924
Schmid AA, Kroenke K, Hendrie HC et al (2011) Poststroke depression and treatment effects on functional outcomes. Neurology 76:1000–1005. https://doi.org/10.1212/WNL.0b013e318210435e
doi: 10.1212/WNL.0b013e318210435e pubmed: 21403112 pmcid: 3271576
House A, Knapp P, Bamford J, Vail A (2001) Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke 32:696–701. https://doi.org/10.1161/01.STR.32.3.696
doi: 10.1161/01.STR.32.3.696 pubmed: 11239189
Van De Weg FB, Kuik DJ, Lankhorst GJ (1999) Post-stroke depression and functional outcome: a cohort study investigating the influence of depression on functional recovery from stroke. Clin Rehabil 13:268–272. https://doi.org/10.1191/026921599672495022
doi: 10.1191/026921599672495022 pubmed: 10392654
Nannetti L, Paci M, Pasquini J et al (2009) Motor and functional recovery in patients with post-stroke depression motor and functional recovery in patients with post-stroke depression. Disabil Rehabil. https://doi.org/10.1080/09638280400009378
doi: 10.1080/09638280400009378
Naess H, Nyland H (2013) Poststroke fatigue and depression are related to mortality in young adults: a cohort study. BMJ Open. https://doi.org/10.1136/bmjopen-2012-002404
doi: 10.1136/bmjopen-2012-002404 pubmed: 23457330 pmcid: 3612756
Mortensen JK, Larsson H, Johnsen SP, Andersen G (2013) Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke. Stroke 44:420–426. https://doi.org/10.1161/STROKEAHA.112.674242
doi: 10.1161/STROKEAHA.112.674242 pubmed: 23306326
Juang HT, Chen PC, Chien KL (2015) Using antidepressants and the risk of stroke recurrence: report from a national representative cohort study. BMC Neurol. https://doi.org/10.1186/s12883-015-0345-x
doi: 10.1186/s12883-015-0345-x pubmed: 26045186 pmcid: 4455315
Dam H, Harhoff M, Andersen PK, Kessing LV (2007) Increased risk of treatment with antidepressants in stroke compared with other chronic illness. Int Clin Psychopharmacol 22:13–19. https://doi.org/10.1097/YIC.0b013e328010357f
doi: 10.1097/YIC.0b013e328010357f pubmed: 17159455
Mortensen JK, Johnsen SP, Andersen G (2018) Prescription and predictors of post-stroke antidepressant treatment: a population-based study. Acta Neurol Scand 138:235–244. https://doi.org/10.1111/ane.12947
doi: 10.1111/ane.12947 pubmed: 29691834
Aho K, Harmsen P, Hatano S et al (1980) Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 58:113–130
pubmed: 6966542 pmcid: 2395897
Putaala J, Metso AJ, Metso TM et al (2009) Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 40:1195–1203. https://doi.org/10.1161/STROKEAHA.108.529883
doi: 10.1161/STROKEAHA.108.529883 pubmed: 19246709
Tilastokeskus—Luokitukset—Sosioekonominen asema (1989) Luokituksen kuvaus. http://www.stat.fi/meta/luokitukset/sosioekon_asema/001-1989/kuvaus.html . Accessed 21 Oct 2018
R Core Team (2020) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
Meng G, Ma X, Li L et al (2017) Predictors of early-onset post-ischemic stroke depression: a cross-sectional study. BMC Neurol 17:199. https://doi.org/10.1186/s12883-017-0980-5
doi: 10.1186/s12883-017-0980-5 pubmed: 29149884 pmcid: 5693521
Putaala J, Kurkinen M, Tarvos V et al (2009) Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke. Neurology 72:1823–1829. https://doi.org/10.1212/WNL.0b013e3181a711df
doi: 10.1212/WNL.0b013e3181a711df pubmed: 19470964
Wu R-H, Li Q, Tan Y et al (2014) Depression in silent lacunar infarction: a cross-sectional study of its association with location of silent lacunar infarction and vascular risk factors. Neurol Sci 35:1553–1559. https://doi.org/10.1007/s10072-014-1794-5
doi: 10.1007/s10072-014-1794-5 pubmed: 24752391 pmcid: 4176570
Boden JM, Fergusson DM, Horwood LJ (2010) Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br J Psychiatry 196:440–446. https://doi.org/10.1192/bjp.bp.109.065912
doi: 10.1192/bjp.bp.109.065912 pubmed: 20513853
Flensborg-Madsen Trine T, Bay von Scholten M, Flachs EM et al (2011) Tobacco smoking as a risk factor for depression. A 26-year population-based follow-up study. J Psychiatr Res 45:143–149. https://doi.org/10.1016/j.jpsychires.2010.06.006
doi: 10.1016/j.jpsychires.2010.06.006 pubmed: 20630542
Shi YZ, Xiang YT, Yang Y et al (2015) Depression after minor stroke: prevalence and predictors. J Psychosom Res 79:143–147. https://doi.org/10.1016/j.jpsychores.2015.03.012
doi: 10.1016/j.jpsychores.2015.03.012 pubmed: 25868687
Weng WC, Huang WY, Chien YY et al (2011) The impact of smoking on the severity of acute ischemic stroke. J Neurol Sci 308:94–97. https://doi.org/10.1016/j.jns.2011.05.046
doi: 10.1016/j.jns.2011.05.046 pubmed: 21665225
Burton JK, Ferguson EEC, Barugh AJ et al (2018) Predicting discharge to institutional long-term care after stroke: a systematic review and metaanalysis. J Am Geriatr Soc 66:161–169. https://doi.org/10.1111/jgs.15101
doi: 10.1111/jgs.15101 pubmed: 28991368

Auteurs

Jenna Broman (J)

Department of Neurology, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00029, Helsinki, Finland. jenna.broman@fimnet.fi.

Karoliina Aarnio (K)

Department of Neurology, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00029, Helsinki, Finland.

Anna But (A)

Department of Public Health, University of Helsinki, Helsinki, Finland.

Ivan Marinkovic (I)

Department of Neurology, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00029, Helsinki, Finland.

Jorge Rodríguez-Pardo (J)

Department of Neurology, La Paz University Hospital, Madrid, Spain.

Markku Kaste (M)

Department of Neurology, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00029, Helsinki, Finland.

Turgut Tatlisumak (T)

Department of Neurology, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00029, Helsinki, Finland.
Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Jukka Putaala (J)

Department of Neurology, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00029, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH